```html

Zygotic Fever (Neonatal Sepsis)

What is Zygotic Fever (Neonatal Sepsis)?

Neonatal sepsis, historically referred to as “zygotic fever,” is a life‑threatening systemic infection that occurs in newborn infants (≤ 28 days of life). The term “zygotic” reflects the fact that the infection can begin in utero or during the peripartum period, before the infant has fully established its own immune defenses. In neonatal sepsis, bacteria, viruses, fungi, or parasites invade the bloodstream, triggering a cascade of inflammatory responses that can rapidly damage multiple organ systems.

Because infants have an immature immune system, reduced skin barrier function, and frequently require invasive procedures (e.g., intravenous lines or mechanical ventilation), they are uniquely vulnerable. Early recognition and prompt treatment dramatically improve survival—mortality rates range from <5 % in well‑resourced settings to >30 % in low‑resource environments.<sup>1</sup>

Common Causes

Neonatal sepsis can be classified as early‑onset (≤ 72 hours after birth) or late‑onset 72 hours). The underlying microorganisms differ between the two groups. Below are the most frequent culprits:

• Group B Streptococcus (GBS) – the leading cause of early‑onset sepsis in many high‑income countries.<sup>2</sup>
• Escherichia coli – especially common in preterm infants and in settings with high rates of maternal colonisation.
• Klebsiella spp. – a frequent pathogen in late‑onset sepsis and in NICUs with high antibiotic use.
• Staphylococcus aureus (including MRSA) – often associated with invasive lines or skin breakdown.
• Coagulase‑negative Staphylococci (CoNS) – the most common cause of late‑onset sepsis in very low‑birth‑weight infants.
• Listeria monocytogenes – acquired transplacentally; risk rises with maternal consumption of unpasteurised dairy or deli meats.
• Enteroviruses & HSV – viral sepsis is less common but can present similarly; HSV infection may be severe in the first month.
• Candida spp. – fungal sepsis is rare but life‑threatening, usually in infants with prolonged central lines or broad‑spectrum antibiotics.
• Ureaplasma & Mycoplasma – emerging pathogens in preterm infants, especially those with bronchopulmonary dysplasia.
• Group A Streptococcus (GAS) – a fulminant cause of sepsis with high mortality if not identified early.

Associated Symptoms

Neonates often cannot verbalise discomfort, so sepsis may manifest as subtle, non‑specific signs. Common accompanying findings include:

• Temperature instability – fever > 38 °C (100.4 °F) or hypothermia < 36.5 °C (97.7 °F)
• Feeding difficulties – poor suck, lethargy, or vomiting
• Respiratory distress – tachypnea, grunting, nasal flaring, or need for supplemental O₂
• Cardiovascular changes – tachycardia or bradycardia, hypotension, prolonged capillary refill
• Skin findings – mottled or mottling, petechiae, purpura, blanching erythema, or a “blanket‑like” rash
• Neurologic signs – irritability, seizures, or decreased responsiveness
• Gastro‑intestinal symptoms – abdominal distension, bloody stools, or bilirubin rise
• Laboratory clues – leukopenia or leukocytosis, thrombocytopenia, metabolic acidosis, elevated C‑reactive protein (CRP) or procalcitonin

Because many of these findings overlap with less‑serious conditions (e.g., transient tachypnea of the newborn), clinicians maintain a low threshold for investigation when any constellation appears.

When to See a Doctor

Any newborn with one or more of the following should be evaluated by a health‑care professional immediately:

• Fever > 38 °C or temperature below 36.5 °C
• Persistent lethargy or extreme irritability
• Difficulty feeding or refusing feeds for > 2 hours
• Rapid breathing (≥ 60 breaths/min) or signs of respiratory struggle
• Blue or grey colour around the lips, tongue, or extremities
• Unexplained rash, especially petechiae or purpura
• Vomiting more than once or ongoing bilious vomiting
• Convulsions or jittery movements
• Any sudden change in the baby’s normal behaviour

If you are caring for a newborn at home and notice any of the above, call your pediatrician or go to the nearest emergency department without delay.

Diagnosis

Diagnosing neonatal sepsis is a combination of clinical suspicion and laboratory testing. The goals are to identify the causative organism quickly and to assess organ dysfunction.

Initial Evaluation

1. Physical Examination – detailed assessment of temperature, respiration, heart rate, perfusion, and skin.
2. Blood Cultures – at least 1 mL per culture bottle; two sets (aerobic and anaerobic) are recommended before antibiotics start.
3. Complete Blood Count (CBC) with Differential – looks for leukopenia/leukocytosis, left shift, or thrombocytopenia.
4. Inflammatory Markers – CRP and procalcitonin rise within 6‑12 hours of infection and aid in monitoring response.
5. Metabolic Panel – checks glucose, electrolytes, renal function, and acid‑base status.

Additional Specimens (as indicated)

• Urine culture – obtained by catheterisation or suprapubic aspiration.
• CSF analysis – lumbar puncture if meningitis is suspected (altered mental status, seizures, bulging fontanel).
• Respiratory specimens – tracheal aspirate or nasopharyngeal swab for viral PCR when respiratory signs dominate.
• Chest X‑ray – evaluates pneumonia, atelectasis, or other lung pathology.

Imaging & Monitoring

• Continuous pulse oximetry and cardiac monitoring in NICU settings.
• Echocardiography if septic shock or endocarditis is suspected.

Treatment Options

Prompt antimicrobial therapy is the cornerstone of care. Treatment is empiric at first, then tailored once culture results return.

Empiric Antibiotic Regimens

Scenario	First‑line Antibiotics (24‑48 h)
Early‑onset sepsis (≤ 72 h)	IV ampicillin + gentamicin OR ampicillin + cefotaxime (if cefotaxime is preferred locally)
Late‑onset sepsis (> 72 h)	IV vancomycin + gentamicin OR vancomycin + cefepime (covers MRSA and gram‑negative organisms)
Suspected Listeria or maternal GBS risk	IV ampicillin + gentamicin

Dosages are weight‑based and adjusted for renal function. Duration typically ranges from 7–14 days, depending on pathogen and clinical response.

Supportive Care

• Fluid resuscitation – isotonic crystalloids (10 mL/kg bolus) to maintain perfusion.
• Vasopressors (e.g., dopamine, norepinephrine) if hypotension persists after fluids.
• Respiratory support – CPAP, nasal cannula, or mechanical ventilation as needed.
• Glucose management – monitor for hypoglycaemia; give dextrose if < 45 mg/dL.
• Temperature regulation – use incubators or cooling blankets to keep the infant normothermic.
• Transfusion of packed red cells or platelets if severe anaemia or thrombocytopenia develops.

Adjunctive Therapies

• Intravenous Immunoglobulin (IVIG) – controversial; may be considered in proven GBS sepsis with severe disease.
• Antifungal agents (e.g., fluconazole or amphotericin B) if Candida is isolated.
• Antiviral therapy (e.g., acyclovir) for HSV infection, started empirically if vesicular lesions or maternal herpes history exist.

Home Care After Discharge

Most infants will stay in the hospital until they are afebrile for 48 hours, have negative repeat blood cultures, and show stable vital signs. For those discharged early, parents should:

• Complete the full antibiotic course (often via a PICC line or oral step‑down therapy).
• Watch closely for fever, feeding changes, or breathing difficulty.
• Keep follow‑up appointments with the pediatrician and, if applicable, the infectious‑disease specialist.
• Maintain hand hygiene and limit exposure to sick contacts.

Prevention Tips

While not all cases are preventable, several strategies markedly reduce risk:

• Maternal screening for Group B Streptococcus at 35‑37 weeks gestation and intrapartum antibiotic prophylaxis if positive.
• Strict aseptic technique for invasive procedures (e.g., umbilical catheter insertion, IV line placement).
• Hand hygiene for all caregivers, health‑care workers, and visitors (WHO “5 Moments” guidelines).
• Breast‑feeding encouragement – breast milk contains antibodies that protect against sepsis‑causing pathogens.
• Limiting unnecessary antibiotic exposure to reduce resistant organism colonisation.
• Prompt treatment of maternal infections (UTIs, chorioamnionitis) during pregnancy.
• Vaccination of pregnant women against influenza and pertussis, which indirectly protect the newborn.
• Environmental cleaning of NICU surfaces and equipment.
• Use of probiotic supplementation in very low birth‑weight infants (evidence suggests reduced NEC and sepsis rates – see NEJM, 2020).
• Avoiding exposure to contaminated foods (e.g., unpasteurised dairy) for pregnant women to reduce Listeria risk.

Emergency Warning Signs

References

1. World Health Organization. Neonatal sepsis: guidelines for prevention and management. WHO Press, 2021.
2. Mayo Clinic. Group B Streptococcus infection in newborns. https://www.mayoclinic.org
3. Centers for Disease Control and Prevention. Early‑Onset Neonatal Sepsis. https://www.cdc.gov
4. American Academy of Pediatrics. Guidelines for the Prevention and Management of Neonatal Sepsis. Pediatrics. 2022;149(5):e2022061001.
5. NIH National Institute of Child Health & Human Development. Neonatal Sepsis Fact Sheet. 2023.
6. Cleveland Clinic. Neonatal Sepsis: Symptoms, Diagnosis, and Treatment. https://my.clevelandclinic.org
7. R. Cotten et al., “Probiotics for Prevention of Late‑Onset Sepsis in Preterm Infants,” New England Journal of Medicine, 2020;382:117‑128.
8. J. O. Linder et al., “Antimicrobial Therapy for Neonatal Sepsis.” The Lancet Infectious Diseases, 2021;21:e300‑e311.

```